Abstract
1. The effects of the class I antiarrhythmic agent, tocainide, on intraventricular conduction were assessed in guinea-pigs, anaesthetized with pentobarbitone sodium 60 mg kg-1, i.p. 2. After electrical ablation of the sinus node, heart rate was controlled by atrial pacing. His bundle electrograms were recorded by means of an epicardial bipolar electrode. 3. During continuous stimulation, comparison of HV intervals measured at a cycle length of 475 ms, with HV intervals measured at a cycle length of 250 ms yielded the following results: 25.26 +/- 0.64 ms versus 25.02 +/- 0.70 ms (NS), at baseline, 26.65 +/- 0.80 ms versus 29.88 +/- 1.13 ms (P < 0.001) after i.v. administration of 30 mg kg-1 tocainide, and 28.04 +/- 0.64 ms versus 36.24 +/- 1.31 ms (P < 0.001), after addition of 20 mg kg-1 tocainide. Thus, tocainide caused HV intervals to increase in a strictly rate-dependent fashion. 4. In order to characterize the rate-dependent class I activity of tocainide in terms of its binding kinetics to sodium channels, fractional sodium channel block was estimated from drug induced reductions of intraventricular conduction velocity (delta theta). On abruptly changing the drive cycle length from 500 ms to 250 ms, delta theta reached a new steady state with rate constants of 1.23 +/- 0.09 beat-1 and 1.28 +/- 0.09 beat-1, after administration of 30 mg kg-1 and addition of 20 mg kg-1 tocainide, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aomine M. Electrophysiological effects of lidocaine on isolated guinea pig Purkinje fibers: comparison with its effects on papillary muscle. Gen Pharmacol. 1989;20(1):99–104. doi: 10.1016/0306-3623(89)90069-4. [DOI] [PubMed] [Google Scholar]
- Borchard U., Hafner D., Ewerbeck S. Electrophysiological and antiarrhythmic actions of tocainide in isolated heart preparations of the guinea pig. Arzneimittelforschung. 1985;35(9):1367–1374. [PubMed] [Google Scholar]
- Campbell T. J. Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br J Pharmacol. 1983 Sep;80(1):33–40. doi: 10.1111/j.1476-5381.1983.tb11046.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
- Campbell T. J. Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST. Cardiovasc Drugs Ther. 1992 Oct;6(5):519–528. doi: 10.1007/BF00055611. [DOI] [PubMed] [Google Scholar]
- Heistracher P. Mechanism of action of antifibrillatory drugs. Naunyn Schmiedebergs Arch Pharmakol. 1971;269(2):199–212. doi: 10.1007/BF01003037. [DOI] [PubMed] [Google Scholar]
- Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
- Kodama I., Toyama J., Takanaka C., Yamada K. Block of activated and inactivated sodium channels by class-I antiarrhythmic drugs studied by using the maximum upstroke velocity (Vmax) of action potential in guinea-pig cardiac muscles. J Mol Cell Cardiol. 1987 Apr;19(4):367–377. doi: 10.1016/s0022-2828(87)80582-5. [DOI] [PubMed] [Google Scholar]
- Nesterenko V. V., Lastra A. A., Rosenshtraukh L. V., Starmer C. F. A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium. J Cardiovasc Pharmacol. 1992 May;19(5):810–820. [PubMed] [Google Scholar]
- Oshita S., Sada H., Kojima M., Ban T. Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):67–82. doi: 10.1007/BF00498433. [DOI] [PubMed] [Google Scholar]
- Packer D. L., Grant A. O., Strauss H. C., Starmer C. F. Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers. J Clin Invest. 1989 Jun;83(6):2109–2119. doi: 10.1172/JCI114124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spinelli W., Hoffman B. F. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circ Res. 1989 Dec;65(6):1565–1579. doi: 10.1161/01.res.65.6.1565. [DOI] [PubMed] [Google Scholar]
- Starmer C. F., Grant A. O., Strauss H. C. Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J. 1984 Jul;46(1):15–27. doi: 10.1016/S0006-3495(84)83994-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starmer C. F., Lastra A. A., Nesterenko V. V., Grant A. O. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. Circulation. 1991 Sep;84(3):1364–1377. doi: 10.1161/01.cir.84.3.1364. [DOI] [PubMed] [Google Scholar]
- Starmer C. F. Theoretical characterization of ion channel blockade: ligand binding to periodically accessible receptors. J Theor Biol. 1986 Mar 21;119(2):235–249. doi: 10.1016/s0022-5193(86)80077-7. [DOI] [PubMed] [Google Scholar]
- Surawicz B. Role of potassium channels in cycle length dependent regulation of action potential duration in mammalian cardiac Purkinje and ventricular muscle fibres. Cardiovasc Res. 1992 Nov;26(11):1021–1029. doi: 10.1093/cvr/26.11.1021. [DOI] [PubMed] [Google Scholar]
- Todt H., Krumpl G., Krejcy K., Raberger G. Mode of QT correction for heart rate: implications for the detection of inhomogeneous repolarization after myocardial infarction. Am Heart J. 1992 Sep;124(3):602–609. doi: 10.1016/0002-8703(92)90266-x. [DOI] [PubMed] [Google Scholar]
- Todt H., Raberger G. Epicardial His bundle recordings in the guinea pig in vivo. J Pharmacol Toxicol Methods. 1992 May;27(3):191–195. doi: 10.1016/1056-8719(92)90040-8. [DOI] [PubMed] [Google Scholar]
- Turgeon J., Wisialowski T. A., Wong W., Altemeier W. A., Wikswo J. P., Jr, Roden D. M. Suppression of longitudinal versus transverse conduction by sodium channel block. Effects of sodium bolus. Circulation. 1992 Jun;85(6):2221–2226. doi: 10.1161/01.cir.85.6.2221. [DOI] [PubMed] [Google Scholar]
- Villemaire C., Savard P., Talajic M., Nattel S. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs. Circulation. 1992 Jun;85(6):2255–2266. doi: 10.1161/01.cir.85.6.2255. [DOI] [PubMed] [Google Scholar]
- Wald R. W., Waxman M. B., Downar E. The effect of antiarrhythmic drugs on depressed conduction and unidirectional block in sheep Purkinje fibers. Circ Res. 1980 May;46(5):612–619. doi: 10.1161/01.res.46.5.612. [DOI] [PubMed] [Google Scholar]
- Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
- Weirich J., Antoni H. Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharmacol. 1990 Jun;15(6):998–1009. doi: 10.1097/00005344-199006000-00019. [DOI] [PubMed] [Google Scholar]
- Weirich J., Antoni H. Evaluation and interpretation of voltage- and frequency-dependent electrophysiologic effects of a new class I antiarrhythmic agent (nicainoprol) on guinea pig papillary muscle and isolated heart. J Cardiovasc Pharmacol. 1988 Dec;12(6):664–671. doi: 10.1097/00005344-198812000-00007. [DOI] [PubMed] [Google Scholar]
- Williams D. O., Scherlag B. J., Hope R. R., El-Sherif N., Lazzara R., Samet P. Selective versus non-selective His bundle pacing. Cardiovasc Res. 1976 Jan;10(1):91–100. doi: 10.1093/cvr/10.1.91. [DOI] [PubMed] [Google Scholar]
